FIELD: pharmaceutical industry.
SUBSTANCE: invention refers to pharmaceutical industry, namely to intra-tumor injection composition. Intraintestinal injection pharmaceutical composition contains sesame oil; ethanol and an immune response modifier compound N-(4-{[4-amino-2-butyl-1H-imidazo[4,5-c][quinolin-1-yl]oxy}butyl)octadecanamide or its pharmaceutically acceptable salt. Disclosed are: a method of delivering a pharmaceutical composition; method of treating a disease in a subject, comprising injecting into a tumor formation an individual in need of treating the disease, composition, wherein the disease is selected from cancer in the head or neck, breast cancer, lymphoma, melanoma, skin T-cell lymphoma and bladder cancer; method of making the composition.
EFFECT: composition described above is effective for intra-tumor injection administration for treating cancer diseases.
15 cl, 11 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
ARYLETHER-SUBSTITUTED IMIDAZOQUINOLINES, PHARMACEUTICAL COMPOSITIONS BASED ON THE SAME, METHODS FOR TREATMENT OF VIRAL DISEASES BASED ON THE SAME AND METHODS FOR TREATMENT OF TUMOR DISEASE BASED ON THE SAME | 2001 |
|
RU2308456C2 |
THIOESTER-SUBSTITUTED IMIDAZOQUINOLINES | 2001 |
|
RU2315049C2 |
4-AMINO-IMIDAZOQUINOLINE DERIVATIVES, USEFUL IN TREATING DISEASES MEDIATED BY TLR7 AND/OR TLR8 AGONISTS | 2015 |
|
RU2698902C2 |
NEW IMIDAZO[4,5-c]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS | 2018 |
|
RU2773516C2 |
HETEROCYCLEL ESTER SUBSTITUTED IMIDAZOQUINOLINES | 2001 |
|
RU2351598C2 |
INDAZOLIE WNT SIGNAL PATHWAY INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | 2017 |
|
RU2682245C1 |
THIOESTER-SUBSTITUTED IMIDAZOQUINOLINES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2304143C2 |
BENZIMIDAZOLE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND USE | 2017 |
|
RU2779534C2 |
2-(AZAINDOL-2-YL)BENZIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS | 2012 |
|
RU2611010C2 |
Authors
Dates
2019-05-13—Published
2014-10-30—Filed